Now in its 5th edition, CNM continues to strengthen connections between schools and research institutions. In Phase I, scientists from the GIMM Foundation and the Champalimaud Foundation introduced the programme to more than 100 8th-grade students at Escola Dr. Azevedo Neves (Damaia, Amadora). Phase II then brought students and teachers into the research environment.

Among the institutions presenting their work was the Champalimaud Foundation, represented by its Digital Surgery Lab. The multidisciplinary research group, co-led by Tiago Marques and João Santinha, showcased projects at the intersection of medicine, engineering and artificial intelligence (AI).

The agreement establishes a long-term framework for collaboration between the two institutions, creating a model that brings university research closer to one of the country’s most advanced scientific infrastructures while fostering the development of new joint initiatives in biomedicine and interdisciplinary research.

Brand rankings and reputation studies are published every year, nationally and internationally, often attracting attention for their league tables and headline positions. While such studies are inevitably shaped by methodological choices, sampling criteria, and contextual factors, they can nonetheless offer a useful lens for understanding how organisations are perceived within a shared ecosystem.

As always, President of the Champalimaud Foundation, Leonor Beleza, was in Hyderabad to participate in the meeting and celebrate the long-standing friendship between the two institutions. Her speech stressed the importance of collaboration in an ever-changing world and a commitment to innovation and disruption in healthcare. These words were echoed by LVPEI’s Executive Chair and Founder, respectively, Drs Prashant Garg, and GN Rao.
 

The patient, aged 37, had a gliosarcoma – an extremely aggressive and rare form of brain cancer. He underwent two surgeries, but the cancer, revealed by symptoms such as aphasia (inability to speak) and weakness in one arm, returned. What followed was reported in Communications Medicine, a scientific journal of the Nature group.

A long-standing friend and collaborator of the Champalimaud Foundation, he played a decisive role in the global recognition of vision science and in strengthening the connection between research, clinical practice, and innovation.

Professor Parreira, Clinical Director of the Champalimaud Clinical Centre since its founding, was distinguished by the President of the Portuguese Republic, Marcelo Rebelo de Sousa, with the rank of Grand Officer of the Order of Public Instruction. The ceremony took place in Palácio de Belém on the 14th of january, 2026.

As a winner of the Outstanding Mid-Career Researcher Award, Inês Pires da Silva was recognised for her exceptional progress and global impact in translational cancer research. She has led international studies that have shaped current clinical practice and advanced scientific understanding of resistance mechanisms in immunotherapy.

Since the 1990s, non-invasive brain stimulation has grown from an experimental idea into an established tool for treating depression as well as advancing neuroscience research. Among these technologies, repetitive transcranial magnetic stimulation (rTMS) is clinically validated and used to treat major depressive disorder, also known as unipolar depression.